Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free GCO Stock Alerts

Genesco (GCO) Financials

Genesco logo
$33.12 -0.04 (-0.12%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$33.21 +0.09 (+0.27%)
As of 07/2/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Genesco

Annual Income Statements for Genesco

This table shows Genesco's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 95 100 -112 -52 61 -56 115 72 -17 -19 13
Consolidated Net Income / (Loss)		 95 97 -112 -52 61 -56 115 72 -17 -19 13
Net Income / (Loss) Continuing Operations		 95 73 37 51 62 -56 115 72 -24 -20 13
Total Pre-Tax Income 		152 113 69 78 82 -112 153 90 -22 9.31 13
Total Operating Income		 151 108 74 82 83 -107 156 93 -13 14 17
Total Gross Profit		 1,443 976 1,011 1,047 1,063 804 1,181 1,136 1,099 1,097 1,127
Total Revenue		 3,022 2,021 2,128 2,189 2,197 1,787 2,422 2,385 2,325 2,325 2,436
Operating Revenue		 3,022 2,021 2,128 2,189 2,197 1,787 2,422 2,385 2,325 2,325 2,436
Total Cost of Revenue		 1,579 1,045 1,116 1,141 1,134 982 1,241 1,249 1,226 1,228 1,309
Operating Cost of Revenue		 1,579 1,045 1,116 1,141 1,134 982 1,241 1,249 1,226 1,228 1,309
Total Operating Expenses		 1,292 868 937 965 980 912 1,026 1,043 1,112 1,083 1,110
Selling, General & Admin Expense		 1,284 876 929 962 966 814 1,034 1,042 1,082 1,080 1,101
Impairment Charge		 7.90 -8.00 7.77 3.16 13 98 -8.06 0.86 30 3.24 8.07
Total Other Income / (Expense), net		 0.28 7.37 -5.38 -3.56 -0.88 -4.42 -2.58 -3.17 -8.31 -4.62 -4.72
Interest Expense		 4.41 5.29 5.42 3.94 1.28 5.09 2.45 2.92 7.78 4.25 4.10
Other Income / (Expense), net		 4.69 13 0.03 0.38 0.40 0.67 -0.13 -0.25 -0.54 -0.37 -0.63
Income Tax Expense		 56 40 32 27 21 -56 38 18 1.85 29 -0.69
Net Income / (Loss) Discontinued Operations		 -0.80 25 -149 -103 -0.37 -0.40 -0.10 -0.33 6.80 0.62 -0.01
Basic Earnings per Share		 $4.13 $4.85 ($5.82) ($2.68) $3.95 ($3.97) $8.11 $5.77 ($1.50) ($1.74) $1.28
Weighted Average Basic Shares Outstanding		 21.31M 20.08M 19.22M 19.35M 15.54M 14.22M 14.17M 12.46M 11.24M 10.84M 10.37M
Diluted Earnings per Share		 $4.11 $4.83 ($5.80) ($2.66) $3.92 ($3.97) $7.92 $5.66 ($1.50) ($1.74) $1.25
Weighted Average Diluted Shares Outstanding		 21.31M 20.08M 19.28M 19.50M 15.67M 14.22M 14.51M 12.71M 11.24M 10.84M 10.62M
Weighted Average Basic & Diluted Shares Outstanding		 21.31M 20.08M 3.73B 18.35M 14.69M 14.96M 13.66M 12.60M 11.48M 11.04M 10.86M

Quarterly Income Statements for Genesco

This table shows Genesco's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026
Net Income / (Loss) Attributable to Common Shareholders		 6.54 27 -24 -9.99 -19 34 -21 -18 5.36 48 -15
Consolidated Net Income / (Loss)		 6.54 27 -24 -9.99 -19 34 -21 -18 5.36 48 -15
Net Income / (Loss) Continuing Operations		 6.59 20 -24 -9.93 -19 34 -21 -18 5.42 48 -15
Total Pre-Tax Income 		8.50 36 -33 -12 8.91 45 -30 -16 7.54 51 -16
Total Operating Income		 11 37 -32 -10 10 46 -28 -14 8.58 51 -15
Total Gross Profit		 278 342 216 246 285 350 221 250 289 367 229
Total Revenue		 579 739 458 525 596 746 474 546 616 800 487
Operating Revenue		 579 739 458 525 596 746 474 546 616 800 487
Total Cost of Revenue		 301 397 241 280 311 396 253 296 328 433 258
Operating Cost of Revenue		 301 397 241 280 311 396 253 296 328 433 258
Total Operating Expenses		 268 305 248 256 275 304 249 264 280 316 244
Selling, General & Admin Expense		 267 304 248 255 275 302 249 264 276 312 254
Impairment Charge		 0.10 1.21 0.58 0.78 0.13 1.75 0.29 0.12 4.33 3.32 -10
Total Other Income / (Expense), net		 -2.36 -1.69 -1.00 -1.43 -1.30 -0.89 -1.52 -1.61 -1.03 -0.56 -0.50
Interest Expense		 2.21 1.54 0.89 1.35 1.21 0.80 1.34 1.46 0.88 0.42 0.27
Other Income / (Expense), net		 -0.15 -0.15 -0.11 -0.09 -0.09 -0.09 -0.18 -0.15 -0.15 -0.15 -0.24
Income Tax Expense		 1.91 15 -8.84 -1.78 28 12 -8.45 2.41 2.12 3.24 -1.07
Net Income / (Loss) Discontinued Operations		 -0.05 6.90 -0.06 -0.06 -0.08 0.83 -0.02 -0.02 -0.07 0.09 -0.01
Basic Earnings per Share		 $0.60 $2.29 ($2.23) ($0.91) ($1.76) $3.16 ($2.02) ($1.79) $0.52 $4.57 ($1.42)
Weighted Average Basic Shares Outstanding		 10.90M 11.24M 10.93M 10.94M 10.74M 10.84M 10.50M 10.29M 10.33M 10.37M 10.43M
Diluted Earnings per Share		 $0.60 $2.29 ($2.23) ($0.91) ($1.76) $3.16 ($2.02) ($1.79) $0.50 $4.56 ($1.42)
Weighted Average Diluted Shares Outstanding		 10.97M 11.24M 10.93M 10.94M 10.74M 10.84M 10.50M 10.29M 10.67M 10.62M 10.43M
Weighted Average Basic & Diluted Shares Outstanding		 11.49M 11.48M 11.63M 11.22M 11.21M 11.04M 10.78M 10.80M 10.79M 10.86M 11.11M

Annual Cash Flow Statements for Genesco

This table details how cash moves in and out of Genesco's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Net Change in Cash & Equivalents		 20 -85 -10 128 -86 134 105 -273 -13 -1.15 71
Net Cash From Operating Activities		 150 165 165 237 117 158 240 -165 95 88 146
Net Cash From Continuing Operating Activities		 150 165 165 237 117 158 240 -165 95 88 146
Net Income / (Loss) Continuing Operations		 95 97 -112 -52 61 -56 115 72 -17 -19 13
Consolidated Net Income / (Loss)		 95 97 -112 -52 61 -56 115 72 -17 -19 13
Depreciation Expense		 79 76 78 77 50 46 43 43 49 52 53
Non-Cash Adjustments To Reconcile Net Income		 18 10 202 155 26 111 -7.06 16 45 16 18
Changes in Operating Assets and Liabilities, net		 -43 -19 -4.29 58 -20 57 89 -296 17 39 61
Net Cash From Investing Activities		 -76 -71 -128 -57 53 -24 -34 -60 -60 -41 -62
Net Cash From Continuing Investing Activities		 -76 -71 -128 -57 53 -24 -34 -60 -60 -41 -62
Purchase of Property, Plant & Equipment		 -101 -94 -128 -57 -30 -24 -54 -60 -60 -41 -62
Acquisitions		 -35 -0.02 0.00 -1.09 -34 0.00 -0.08 0.00 0.00 0.00 0.00
Divestitures		 - - 0.25 0.31 116 0.11 20 0.00 0.09 0.00 0.00
Other Investing Activities, net		 - 0.00 0.00 1.51 0.17 0.00 0.07 0.00 0.22 0.00 0.00
Net Cash From Financing Activities		 -52 -178 -47 -53 -257 -3.16 -101 -46 -48 -47 -13
Net Cash From Continuing Financing Activities		 -52 -178 -47 -53 -257 -3.16 -101 -46 -48 -47 -13
Repayment of Debt		 -340 -376 -544 -305 -157 -222 -47 -303 -491 -457 -442
Repurchase of Common Equity		 -142 -140 -16 -45 -190 -1.22 -82 -81 -34 -12 -14
Issuance of Debt		 429 341 516 300 93 221 29 339 478 422 445
Other Financing Activities, net		 0.79 -2.42 -3.15 -3.21 -2.36 -1.35 -1.28 -0.14 -0.01 0.00 -1.60
Effect of Exchange Rate Changes		 -1.34 -1.08 - - 0.10 3.12 0.63 -2.19 -0.05 -0.90 1.01
Cash Interest Paid		 3.41 4.26 5.35 3.34 3.01 4.39 2.33 2.74 7.84 4.48 4.35
Cash Income Taxes Paid		 59 52 37 12 4.90 7.69 -0.18 51 5.89 3.51 -59

Quarterly Cash Flow Statements for Genesco

This table details how cash moves in and out of Genesco's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026
Net Change in Cash & Equivalents		 -16 13 -16 27 -12 0.43 -12 19 -14 78 -78
Net Cash From Operating Activities		 1.60 118 -34 28 -23 117 -101 86 -13 173 -103
Net Cash From Continuing Operating Activities		 1.60 118 -34 28 -23 117 -101 86 -13 173 -103
Net Income / (Loss) Continuing Operations		 6.54 27 -24 -9.99 -19 34 -21 -18 5.36 48 -15
Consolidated Net Income / (Loss)		 6.54 27 -24 -9.99 -19 34 -21 -18 5.36 48 -15
Depreciation Expense		 12 14 13 13 13 13 13 13 13 13 13
Non-Cash Adjustments To Reconcile Net Income		 3.82 3.70 3.62 3.70 3.66 4.56 3.39 3.26 7.71 3.35 3.85
Changes in Operating Assets and Liabilities, net		 -21 73 -26 21 -21 65 -97 88 -39 109 -105
Net Cash From Investing Activities		 -14 -10 -6.38 -7.90 -13 -14 -19 -15 -19 -9.87 -15
Net Cash From Continuing Investing Activities		 -14 -10 -6.38 -7.90 -13 -14 -19 -15 -19 -9.87 -15
Purchase of Property, Plant & Equipment		 -14 -11 -6.38 -7.90 -13 -14 -19 -15 -19 -9.87 -15
Net Cash From Financing Activities		 -1.91 -95 24 6.68 24 -102 107 -52 18 -86 40
Net Cash From Continuing Financing Activities		 -1.91 -95 24 6.68 24 -102 107 -52 18 -86 40
Repayment of Debt		 -123 -207 -58 -97 -123 -179 -68 -114 -115 -145 -10
Repurchase of Common Equity		 -0.04 - 0.00 -11 -0.44 -0.50 -13 -0.50 -0.05 -0.11 -2.11
Issuance of Debt		 121 112 83 114 147 78 189 62 132 61 53
Other Financing Activities, net		 - - -0.77 - - - 0.00 - - -1.59 -0.14
Effect of Exchange Rate Changes		 -0.97 0.26 - - 0.30 -1.28 0.35 0.02 0.01 0.64 -0.11
Cash Interest Paid		 2.33 2.13 0.76 1.23 1.30 1.19 0.74 1.78 0.84 0.99 0.38
Cash Income Taxes Paid		 1.67 0.40 1.12 0.47 0.69 1.23 0.39 -57 0.02 -2.58 0.22

Annual Balance Sheets for Genesco

This table presents Genesco's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Total Assets		 1,541 1,441 1,315 1,181 1,680 1,587 1,562 1,456 1,330 1,336 1,393
Total Current Assets		 800 717 693 731 508 668 710 573 507 609 619
Cash & Equivalents		 133 48 40 167 81 215 321 48 35 34 105
Accounts Receivable		 47 44 34 132 29 31 40 41 54 49 40
Inventories, net		 530 564 388 367 365 291 278 458 379 425 434
Prepaid Expenses		 61 61 54 65 32 130 72 26 40 101 39
Plant, Property, & Equipment, net		 323 331 299 277 238 208 216 234 240 228 238
Total Noncurrent Assets		 418 393 324 173 934 712 636 650 582 499 537
Goodwill		 281 271 100 93 122 39 39 38 9.57 8.86 9.46
Intangible Assets		 3.57 2.39 1.34 0.94 36 31 30 27 27 26 28
Noncurrent Deferred & Refundable Income Taxes		 0.96 13 25 21 19 0.00 1.47 29 83 0.39 0.25
Other Noncurrent Operating Assets		 132 106 58 57 756 642 566 556 462 463 499
Total Liabilities & Shareholders' Equity		 1,541 1,441 1,315 1,181 1,680 1,587 1,562 1,456 1,330 1,336 1,393
Total Liabilities		 584 518 485 444 1,061 1,021 960 849 759 789 826
Total Current Liabilities		 324 309 255 276 362 403 432 361 320 380 376
Short-Term Debt		 14 9.18 1.77 8.99 - - - - - - 0.00
Accounts Payable		 154 171 123 159 136 150 152 145 115 168 157
Accrued Expenses		 79 64 51 45 83 79 134 81 76 88 100
Other Current Liabilities		 - - 1.90 0.55 143 174 145 134 129 124 119
Total Noncurrent Liabilities		 261 209 230 167 699 618 528 489 439 409 450
Long-Term Debt		 98 74 87 57 14 33 16 45 35 0.00 3.38
Other Noncurrent Operating Liabilities		 - - 1.71 111 685 585 512 444 404 409 446
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 957 923 831 738 619 567 602 607 571 547 567
Total Preferred & Common Equity		 955 921 829 738 619 567 602 607 571 547 567
Preferred Stock		 1.08 1.06 1.05 1.06 1.01 1.01 0.83 0.82 0.81 0.84 0.84
Total Common Equity		 954 920 828 736 618 566 602 606 570 546 566
Common Stock		 246 258 271 284 289 298 306 318 331 344 355
Retained Earnings		 768 731 604 509 379 321 350 347 297 266 266
Treasury Stock		 -18 -18 -18 -18 -18 -18 -18 -18 -18 -18 -18
Accumulated Other Comprehensive Income / (Loss)		 -43 -51 -29 -38 -32 -35 -36 -41 -40 -45 -37

Quarterly Balance Sheets for Genesco

This table presents Genesco's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 7/29/2023 10/28/2023 5/4/2024 8/3/2024 11/2/2024 5/3/2025 8/2/2025 11/1/2025 5/2/2026
Total Assets		 1,495 1,493 1,307 1,384 1,436 1,405 1,422 1,472 1,384
Total Current Assets		 625 639 508 607 660 633 646 689 596
Cash & Equivalents		 37 22 19 46 34 22 41 27 27
Accounts Receivable		 50 57 50 57 52 53 54 56 48
Inventories, net		 491 517 393 450 523 451 501 558 477
Prepaid Expenses		 46 43 46 53 51 108 50 48 44
Plant, Property, & Equipment, net		 244 245 234 229 230 237 239 241 240
Total Noncurrent Assets		 626 609 566 548 546 534 537 542 549
Goodwill		 9.72 9.28 9.42 9.28 9.23 9.32 9.34 9.18 9.48
Intangible Assets		 28 26 27 27 27 28 27 27 28
Noncurrent Deferred & Refundable Income Taxes		 86 33 26 25 59 0.39 0.39 0.39 0.25
Other Noncurrent Operating Assets		 502 540 503 486 450 497 500 505 511
Total Liabilities & Shareholders' Equity		 1,495 1,493 1,307 1,384 1,436 1,405 1,422 1,472 1,384
Total Liabilities		 962 956 759 851 919 882 916 958 832
Total Current Liabilities		 383 397 308 396 422 331 414 436 325
Short-Term Debt		 - - 0.00 0.00 0.00 7.30 13 20 0.00
Accounts Payable		 167 187 109 187 215 122 193 213 129
Accrued Expenses		 79 76 74 86 84 75 85 83 80
Other Current Liabilities		 137 135 125 123 123 127 123 120 116
Total Noncurrent Liabilities		 579 559 451 455 497 551 501 522 507
Long-Term Debt		 132 128 59 78 100 114 58 70 45
Other Noncurrent Operating Liabilities		 448 431 391 378 396 438 444 453 461
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 533 537 548 533 517 522 506 514 552
Total Preferred & Common Equity		 533 537 548 533 517 522 506 514 552
Preferred Stock		 0.81 0.81 0.81 0.81 0.82 0.84 0.84 0.84 0.84
Total Common Equity		 532 536 548 532 516 521 506 513 552
Common Stock		 325 328 334 337 340 346 349 352 358
Retained Earnings		 263 270 272 251 232 232 213 218 249
Treasury Stock		 -18 -18 -18 -18 -18 -18 -18 -18 -18
Accumulated Other Comprehensive Income / (Loss)		 -38 -44 -41 -39 -39 -39 -38 -39 -37

Annual Metrics And Ratios for Genesco

This table displays calculated financial ratios and metrics derived from Genesco's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
DEI Shares Outstanding		 22,090,544.00 19,870,665.00 19,913,201.00 20,192,544.00 14,700,187.00 14,992,078.00 14,607,160.00 12,609,875.00 - - 10,792,736.00
DEI Adjusted Shares Outstanding		 22,090,544.00 19,870,665.00 19,913,201.00 20,192,544.00 14,700,187.00 14,992,078.00 14,607,160.00 12,609,875.00 - - 10,792,736.00
DEI Earnings Per Adjusted Shares Outstanding		 4.28 5.02 -5.62 -2.57 4.18 -3.76 7.86 5.70 - - 1.23
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 5.68% -33.13% 5.28% 2.87% 0.39% -18.69% 35.57% -1.54% -2.53% 0.02% 4.78%
EBITDA Growth		 0.23% -16.44% -22.10% 3.69% -16.24% -145.08% 430.24% -31.55% -73.90% 86.27% 6.05%
EBIT Growth		 -2.67% -22.78% -38.21% 10.48% 1.84% -227.31% 245.84% -40.17% -115.05% 196.86% 23.09%
NOPAT Growth		 -10.08% -26.82% -43.20% 35.33% 16.55% -220.28% 255.69% -36.02% -112.60% -209.81% 162.54%
Net Income Growth		 -3.23% 3.03% -214.79% 53.57% 218.21% -191.93% 303.53% -37.38% -123.40% -12.26% 170.24%
EPS Growth		 -0.24% 17.52% -220.08% 54.14% 247.37% -201.28% 299.50% -28.54% -126.50% -16.00% 171.84%
Operating Cash Flow Growth		 -21.13% 10.40% -0.40% 44.08% -50.59% 34.63% 52.07% -168.74% 157.49% -7.29% 65.85%
Free Cash Flow Firm Growth		 -7.12% -21.26% 536.85% -87.22% 207.23% -36.60% 120.23% -213.49% 110.23% 20.66% 131.67%
Invested Capital Growth		 2.26% 1.19% -34.53% 0.96% -13.15% -30.36% -22.63% 102.89% -5.48% -10.12% -9.35%
Revenue Q/Q Growth		 1.33% -30.73% 5.73% 31.53% 0.10% -2.23% 3.90% -0.11% 0.60% 0.30% 2.27%
EBITDA Q/Q Growth		 -4.25% -13.18% 445.20% -52.74% -8.32% 21.01% 11.42% -19.71% -21.23% 13.55% 8.08%
EBIT Q/Q Growth		 -7.02% -19.03% 160.98% -68.05% -6.17% 13.97% 15.25% -26.51% -921.68% 189.08% 44.56%
NOPAT Q/Q Growth		 -8.89% -26.58% 146.33% -76.69% 10.11% 13.86% -19.81% -22.95% -1,344.21% -914.47% 1,636.26%
Net Income Q/Q Growth		 -5.71% 1.97% 7.83% -176.27% 260.91% 49.06% -19.48% -24.38% -232.09% 27.57% 33,923.08%
EPS Q/Q Growth		 -3.97% 8.05% 9.52% -175.35% 349.68% 0.00% 0.00% -18.33% -102.70% 33.33% 933.33%
Operating Cash Flow Q/Q Growth		 42.62% -26.04% 6.27% 0.73% -35.50% -4.78% -7.23% -5.55% 70.66% -1.50% 63.05%
Free Cash Flow Firm Q/Q Growth		 127.79% -63.74% 645.91% -90.96% 55.61% -24.55% -2.08% -19.12% 186.23% -55.05% 1,001.58%
Invested Capital Q/Q Growth		 -16.01% -9.74% -32.32% 0.18% -7.58% -0.80% -8.50% -2.07% -11.30% -12.08% -19.30%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 47.76% 48.29% 47.54% 47.84% 48.39% 45.03% 48.77% 47.64% 47.27% 47.17% 46.26%
EBITDA Margin		 7.80% 9.75% 7.21% 7.27% 6.07% -3.36% 8.19% 5.69% 1.52% 2.84% 2.87%
Operating Margin		 5.00% 5.33% 3.50% 3.74% 3.79% -6.00% 6.42% 3.91% -0.58% 0.60% 0.71%
EBIT Margin		 5.16% 5.96% 3.50% 3.76% 3.81% -5.97% 6.42% 3.90% -0.60% 0.58% 0.69%
Profit (Net Income) Margin		 3.13% 4.82% -5.26% -2.37% 2.79% -3.16% 4.74% 3.02% -0.72% -0.81% 0.54%
Tax Burden Percent		 62.41% 86.41% -162.11% -66.36% 74.46% 50.53% 75.07% 79.84% 77.28% -202.94% 105.38%
Interest Burden Percent		 97.18% 93.65% 92.73% 95.21% 98.47% 104.78% 98.43% 96.86% 155.56% 68.65% 75.44%
Effective Tax Rate		 37.06% 35.36% 46.79% 34.55% 25.08% 0.00% 24.87% 19.80% 0.00% 309.63% -5.44%
Return on Invested Capital (ROIC)		 10.12% 7.28% 4.97% 8.46% 10.51% -16.02% 34.26% 16.59% -1.60% -5.39% 3.73%
ROIC Less NNEP Spread (ROIC-NNEP)		 11.82% 171.81% 192.90% 78.23% 11.73% -30.99% 35.10% 18.45% 409.21% -65.13% 11.07%
Return on Net Nonoperating Assets (RNNOA)		 -0.45% 3.08% -17.73% -15.08% -1.46% 6.51% -14.62% -4.70% -1.25% 2.01% -1.35%
Return on Equity (ROE)		 9.67% 10.37% -12.76% -6.62% 9.05% -9.52% 19.65% 11.89% -2.86% -3.38% 2.38%
Cash Return on Invested Capital (CROIC)		 7.89% 6.10% 46.71% 7.51% 24.58% 19.76% 59.77% -51.35% 4.03% 5.27% 13.54%
Operating Return on Assets (OROA)		 9.98% 8.08% 5.40% 6.59% 5.85% -6.52% 9.87% 6.16% -1.00% 1.02% 1.22%
Return on Assets (ROA)		 6.05% 6.53% -8.12% -4.16% 4.29% -3.45% 7.29% 4.76% -1.21% -1.42% 0.97%
Return on Common Equity (ROCE)		 9.64% 10.34% -12.72% -6.61% 9.03% -9.50% 19.61% 11.88% -2.85% -3.37% 2.38%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2.95% -3.45% 0.00%
Net Operating Profit after Tax (NOPAT)		 95 70 40 54 62 -75 117 75 -9.42 -29 18
NOPAT Margin		 3.15% 3.45% 1.86% 2.45% 2.84% -4.20% 4.83% 3.14% -0.41% -1.26% 0.75%
Net Nonoperating Expense Percent (NNEP)		 -1.70% -164.53% -187.93% -69.77% -1.23% 14.97% -0.83% -1.86% -410.82% 59.75% -7.33%
Return On Investment Capital (ROIC_SIMPLE)		 8.91% 6.93% 4.31% 6.67% 9.85% -12.52% 18.91% 11.47% -1.56% -5.34% 3.20%
Cost of Revenue to Revenue		 52.24% 51.71% 52.46% 52.16% 51.61% 54.97% 51.23% 52.36% 52.73% 52.83% 53.74%
SG&A Expenses to Revenue		 42.50% 43.36% 43.68% 43.96% 43.99% 45.55% 42.68% 43.70% 46.55% 46.44% 45.21%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 42.76% 42.96% 44.04% 44.10% 44.60% 51.03% 42.34% 43.73% 47.85% 46.57% 45.55%
Earnings before Interest and Taxes (EBIT)		 156 120 74 82 84 -107 155 93 -14 14 17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 236 197 153 159 133 -60 198 136 35 66 70
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.53 1.28 0.80 1.24 0.93 1.03 1.53 0.99 0.58 0.86 0.55
Price to Tangible Book Value (P/TBV)		 2.18 1.82 0.91 1.42 1.26 1.17 1.72 1.11 0.62 0.91 0.59
Price to Revenue (P/Rev)		 0.48 0.58 0.31 0.42 0.26 0.33 0.38 0.25 0.14 0.20 0.13
Price to Earnings (P/E)		 15.45 11.80 0.00 0.00 9.42 0.00 8.01 8.37 0.00 0.00 23.53
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 6.47% 8.47% 0.00% 0.00% 10.62% 0.00% 12.49% 11.94% 0.00% 0.00% 4.25%
Enterprise Value to Invested Capital (EV/IC)		 1.52 1.26 1.13 1.27 0.93 1.04 2.07 0.99 0.58 0.85 0.45
Enterprise Value to Revenue (EV/Rev)		 0.48 0.60 0.33 0.37 0.23 0.22 0.25 0.25 0.14 0.19 0.09
Enterprise Value to EBITDA (EV/EBITDA)		 6.12 6.17 4.63 5.09 3.84 0.00 3.10 4.42 9.35 6.57 3.01
Enterprise Value to EBIT (EV/EBIT)		 9.25 10.09 9.56 9.86 6.12 0.00 3.96 6.45 0.00 32.00 12.65
Enterprise Value to NOPAT (EV/NOPAT)		 15.15 17.45 17.97 15.14 8.20 0.00 5.26 8.02 0.00 0.00 11.56
Enterprise Value to Operating Cash Flow (EV/OCF)		 9.64 7.36 4.32 3.42 4.37 2.54 2.57 0.00 3.50 4.94 1.45
Enterprise Value to Free Cash Flow (EV/FCFF)		 19.45 20.82 1.91 17.06 3.51 4.33 3.02 0.00 13.99 15.18 3.19
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.12 0.09 0.11 0.09 0.02 0.06 0.03 0.07 0.06 0.00 0.01
Long-Term Debt to Equity		 0.10 0.08 0.10 0.08 0.02 0.06 0.03 0.07 0.06 0.00 0.01
Financial Leverage		 -0.04 0.02 -0.09 -0.19 -0.12 -0.21 -0.42 -0.25 0.00 -0.03 -0.12
Leverage Ratio		 1.60 1.59 1.57 1.59 2.11 2.76 2.69 2.50 2.37 2.38 2.45
Compound Leverage Factor		 1.55 1.49 1.46 1.52 2.08 2.89 2.65 2.42 3.68 1.64 1.85
Debt to Total Capital		 10.46% 8.25% 9.62% 8.18% 2.27% 5.50% 2.54% 6.88% 5.72% 0.00% 0.59%
Short-Term Debt to Total Capital		 1.33% 0.91% 0.19% 1.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 9.13% 7.33% 9.42% 7.06% 2.27% 5.50% 2.54% 6.88% 5.72% 0.00% 0.59%
Preferred Equity to Total Capital		 0.10% 0.11% 0.11% 0.13% 0.16% 0.17% 0.13% 0.13% 0.13% 0.15% 0.15%
Noncontrolling Interests to Total Capital		 0.15% 0.15% 0.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 89.29% 91.50% 90.10% 91.68% 97.57% 94.33% 97.33% 92.99% 94.14% 99.85% 99.26%
Debt to EBITDA		 0.47 0.42 0.58 0.41 0.11 -0.55 0.08 0.33 0.98 0.00 0.05
Net Debt to EBITDA		 -0.09 0.18 0.32 -0.64 -0.50 3.03 -1.54 -0.02 -0.01 0.00 -1.46
Long-Term Debt to EBITDA		 0.41 0.37 0.56 0.36 0.11 -0.55 0.08 0.33 0.98 0.00 0.05
Debt to NOPAT		 1.17 1.19 2.23 1.23 0.23 -0.44 0.13 0.60 -3.68 0.00 0.19
Net Debt to NOPAT		 -0.23 0.50 1.22 -1.90 -1.07 2.43 -2.61 -0.04 0.05 0.00 -5.59
Long-Term Debt to NOPAT		 1.03 1.06 2.19 1.06 0.23 -0.44 0.13 0.60 -3.68 0.00 0.19
Altman Z-Score		 4.86 4.09 3.66 4.38 2.22 1.73 2.98 2.78 2.46 2.61 2.49
Noncontrolling Interest Sharing Ratio		 0.30% 0.28% 0.29% 0.23% 0.15% 0.17% 0.16% 0.14% 0.14% 0.15% 0.15%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.47 2.32 2.72 2.65 1.40 1.66 1.64 1.59 1.59 1.60 1.64
Quick Ratio		 0.56 0.30 0.29 1.09 0.31 0.61 0.83 0.25 0.28 0.22 0.39
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 74 58 372 48 146 93 204 -231 24 29 66
Operating Cash Flow to CapEx		 367.42% 233.02% 128.73% 414.37% 393.62% 653.71% 444.99% -275.11% 157.20% 213.67% 234.89%
Free Cash Flow to Firm to Interest Expense		 16.80 11.03 68.60 12.07 114.27 18.19 83.30 -79.26 3.05 6.72 16.15
Operating Cash Flow to Interest Expense		 33.91 31.21 30.37 60.22 91.68 30.99 97.99 -56.47 12.19 20.68 35.57
Operating Cash Flow Less CapEx to Interest Expense		 24.68 17.82 6.78 45.69 68.39 26.25 75.97 -76.99 4.44 11.00 20.43
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.93 1.36 1.54 1.75 1.54 1.09 1.54 1.58 1.67 1.74 1.79
Accounts Receivable Turnover		 58.95 44.52 55.16 26.37 27.19 58.96 68.31 59.38 49.23 45.37 54.94
Inventory Turnover		 2.80 1.91 2.34 3.02 3.10 2.99 4.36 3.39 2.93 3.05 3.05
Fixed Asset Turnover		 9.61 6.18 6.76 7.60 8.52 8.01 11.42 10.60 9.81 9.93 10.46
Accounts Payable Turnover		 9.55 6.43 7.59 8.10 7.70 6.86 8.19 8.40 9.44 8.69 8.06
Days Sales Outstanding (DSO)		 6.19 8.20 6.62 13.84 13.42 6.19 5.34 6.15 7.41 8.04 6.64
Days Inventory Outstanding (DIO)		 130.38 190.97 155.67 120.72 117.80 121.95 83.70 107.60 124.61 119.49 119.75
Days Payable Outstanding (DPO)		 38.21 56.76 48.08 45.07 47.38 53.19 44.55 43.48 38.65 42.00 45.28
Cash Conversion Cycle (CCC)		 98.36 142.41 114.21 89.49 83.84 74.95 44.50 70.27 93.37 85.53 81.12
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 951 962 630 636 552 385 298 604 571 513 465
Invested Capital Turnover		 3.21 2.11 2.67 3.46 3.70 3.81 7.10 5.29 3.96 4.29 4.98
Increase / (Decrease) in Invested Capital		 21 11 -332 6.02 -84 -168 -87 306 -33 -58 -48
Enterprise Value (EV)		 1,442 1,215 711 811 512 401 615 600 331 434 211
Market Capitalization		 1,461 1,178 660 911 578 582 919 602 331 467 312
Book Value per Share		 $43.19 $46.30 $41.59 $36.47 $42.06 $37.74 $41.19 $48.07 $49.65 $48.71 $52.46
Tangible Book Value per Share		 $30.29 $32.53 $36.48 $31.82 $31.28 $33.10 $36.50 $42.87 $46.44 $45.59 $49.00
Total Capital		 1,069 1,005 919 803 634 600 618 652 606 547 570
Total Debt		 112 83 88 66 14 33 16 45 35 0.00 3.38
Total Long-Term Debt		 98 74 87 57 14 33 16 45 35 0.00 3.38
Net Debt		 -22 35 48 -102 -67 -182 -305 -3.13 -0.47 -34 -102
Capital Expenditures (CapEx)		 41 71 128 57 30 24 54 60 60 41 62
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 357 368 400 296 65 50 -42 164 153 195 137
Debt-free Net Working Capital (DFNWC)		 491 417 440 464 146 265 278 212 188 229 242
Net Working Capital (NWC)		 476 408 438 455 146 265 278 212 188 229 242
Net Nonoperating Expense (NNE)		 0.63 -28 151 105 1.03 -19 2.03 2.87 7.41 -10 4.99
Net Nonoperating Obligations (NNO)		 -5.90 40 -201 -102 -67 -182 -305 -3.13 -0.47 -34 -102
Total Depreciation and Amortization (D&A)		 80 77 79 77 50 46 43 43 49 52 53
Debt-free, Cash-free Net Working Capital to Revenue		 11.82% 18.23% 18.79% 13.55% 2.95% 2.77% -1.75% 6.87% 6.57% 8.39% 5.61%
Debt-free Net Working Capital to Revenue		 16.23% 20.62% 20.67% 21.19% 6.66% 14.81% 11.48% 8.88% 8.08% 9.85% 9.94%
Net Working Capital to Revenue		 15.77% 20.17% 20.59% 20.78% 6.66% 14.81% 11.48% 8.88% 8.08% 9.85% 9.94%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $4.13 $4.85 ($5.82) ($2.68) $3.95 ($3.97) $8.11 $5.77 ($1.50) ($1.74) $1.28
Adjusted Weighted Average Basic Shares Outstanding		 21.31M 19.61M 19.92M 18.35M 15.54M 14.22M 14.17M 12.46M 11.24M 10.84M 10.37M
Adjusted Diluted Earnings per Share		 $4.11 $4.83 ($5.82) ($2.66) $3.92 ($3.97) $7.92 $5.66 ($1.50) ($1.74) $1.25
Adjusted Weighted Average Diluted Shares Outstanding		 21.31M 19.61M 19.92M 18.35M 15.67M 14.22M 14.51M 12.71M 11.24M 10.84M 10.62M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 21.31M 19.61M 19.92M 18.35M 14.69M 14.96M 13.66M 12.60M 11.48M 11.04M 10.86M
Normalized Net Operating Profit after Tax (NOPAT)		 100 65 44 56 72 -6.52 111 75 12 12 18
Normalized NOPAT Margin		 3.31% 3.19% 2.05% 2.54% 3.30% -0.36% 4.58% 3.16% 0.51% 0.52% 0.73%
Pre Tax Income Margin		 5.01% 5.58% 3.24% 3.58% 3.75% -6.25% 6.32% 3.78% -0.94% 0.40% 0.52%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 35.33 22.74 13.73 20.87 65.50 -20.94 63.50 31.85 -1.80 3.19 4.07
NOPAT to Interest Expense		 21.57 13.16 7.30 13.60 48.84 -14.75 47.75 25.61 -1.21 -6.87 4.45
EBIT Less CapEx to Interest Expense		 26.10 9.35 -9.86 6.34 42.21 -25.68 41.48 11.32 -9.55 -6.49 -11.07
NOPAT Less CapEx to Interest Expense		 12.34 -0.24 -16.29 -0.93 25.55 -19.49 25.73 5.09 -8.97 -16.55 -10.69
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 150.21% 144.20% -14.45% -86.53% 310.15% -2.17% 71.52% 113.21% -203.70% -65.44% 104.63%

Quarterly Metrics And Ratios for Genesco

This table displays calculated financial ratios and metrics derived from Genesco's official financial filings.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026
DEI Shares Outstanding		 11,505,683.00 - - - - - 11,038,311.00 10,778,805.00 10,795,425.00 10,792,736.00 10,858,224.00
DEI Adjusted Shares Outstanding		 11,505,683.00 - - - - - 11,038,311.00 10,778,805.00 10,795,425.00 10,792,736.00 10,858,224.00
DEI Earnings Per Adjusted Shares Outstanding		 0.57 - - - - - -1.92 -1.71 0.50 4.41 -1.36
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -4.05% 1.92% -5.32% 0.41% 2.94% 0.95% 3.58% 3.96% 3.34% 7.24% 2.75%
EBITDA Growth		 -37.23% -15.73% -60.98% 110.43% 0.63% 15.40% 21.41% -139.66% -6.00% 8.87% 84.15%
EBIT Growth		 -58.87% -25.36% -39.62% 73.28% -5.42% 23.86% 12.14% -40.81% -16.76% 11.18% 44.88%
NOPAT Growth		 -60.31% -47.27% -39.71% 73.40% -356.63% 61.00% 12.40% -40.55% 128.55% 40.45% 45.37%
Net Income Growth		 -67.91% -30.19% -28.89% 68.44% -389.52% 26.45% 12.81% -84.86% 128.29% 38.48% 30.21%
EPS Growth		 -63.64% -24.92% -39.38% 67.38% -393.33% 37.99% 9.42% -96.70% 128.41% 44.30% 29.70%
Operating Cash Flow Growth		 108.07% 49.63% 44.17% -21.51% -1,546.96% -1.13% -199.42% 211.54% 44.09% 48.18% -1.72%
Free Cash Flow Firm Growth		 93.19% 120.44% 121.37% 161.69% 308.70% 69.22% -190.87% -67.18% -65.20% 4.37% 176.27%
Invested Capital Growth		 4.35% -5.48% -12.01% -9.97% -9.32% -10.12% 5.58% -5.01% -1.23% -9.35% -8.18%
Revenue Q/Q Growth		 10.76% 27.56% -38.07% 14.77% 13.55% 25.09% -36.46% 15.19% 12.87% 29.81% -39.12%
EBITDA Q/Q Growth		 185.49% 122.08% -137.14% 114.78% 725.13% 154.70% -125.29% 92.54% 2,055.83% 194.99% -103.68%
EBIT Q/Q Growth		 127.61% 247.19% -186.74% 67.86% 197.72% 354.67% -161.53% 48.50% 157.77% 507.27% -130.51%
NOPAT Q/Q Growth		 131.12% 152.52% -205.84% 68.02% -200.28% 258.42% -157.59% 48.69% 160.99% 679.46% -122.40%
Net Income Q/Q Growth		 120.65% 315.80% -189.55% 58.96% -89.47% 281.60% -161.74% 12.98% 129.00% 788.93% -131.11%
EPS Q/Q Growth		 121.51% 281.67% -197.38% 59.19% -93.41% 279.55% -163.92% 11.39% 127.93% 812.00% -131.14%
Operating Cash Flow Q/Q Growth		 -95.48% 7,319.19% -128.52% 182.13% -183.27% 606.93% -186.36% 185.46% -114.95% 1,443.44% -159.28%
Free Cash Flow Firm Q/Q Growth		 79.50% 395.46% 6.43% -4.32% -30.63% 139.56% -157.15% 134.55% -26.43% 618.39% -58.24%
Invested Capital Q/Q Growth		 2.60% -11.30% 3.14% -4.08% 3.34% -12.08% 21.16% -13.71% 7.44% -19.30% 22.72%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 48.06% 46.29% 47.26% 46.77% 47.84% 46.87% 46.67% 45.78% 46.84% 45.89% 47.00%
EBITDA Margin		 3.98% 6.92% -4.15% 0.53% 3.89% 7.91% -3.15% -0.20% 3.54% 8.03% -0.49%
Operating Margin		 1.87% 5.05% -7.02% -1.96% 1.71% 6.18% -5.94% -2.64% 1.39% 6.42% -3.16%
EBIT Margin		 1.85% 5.03% -7.04% -1.97% 1.70% 6.17% -5.98% -2.67% 1.37% 6.40% -3.21%
Profit (Net Income) Margin		 1.13% 3.68% -5.32% -1.90% -3.17% 4.61% -4.48% -3.38% 0.87% 5.95% -3.04%
Tax Burden Percent		 76.96% 76.32% 73.50% 85.37% -212.46% 76.02% 71.56% 115.11% 71.01% 93.80% 93.29%
Interest Burden Percent		 79.38% 95.87% 102.76% 112.98% 88.02% 98.26% 104.73% 110.00% 89.51% 99.19% 101.70%
Effective Tax Rate		 22.46% 43.05% 0.00% 0.00% 311.51% 25.82% 0.00% 0.00% 28.12% 6.38% 0.00%
Return on Invested Capital (ROIC)		 5.33% 11.38% -17.97% -5.29% -13.68% 19.68% -16.08% -7.94% 4.11% 29.92% -9.08%
ROIC Less NNEP Spread (ROIC-NNEP)		 3.04% -318.12% -20.90% -9.73% -10.61% 18.70% -18.27% -34.95% 2.86% 30.57% -15.97%
Return on Net Nonoperating Assets (RNNOA)		 0.45% 0.97% -2.34% -1.15% -1.74% -0.58% -2.38% -2.08% 0.36% -3.73% -1.75%
Return on Equity (ROE)		 5.78% 12.36% -20.31% -6.44% -15.43% 19.10% -18.47% -10.03% 4.47% 26.19% -10.83%
Cash Return on Invested Capital (CROIC)		 -4.36% 4.03% 10.26% 11.17% 10.36% 5.27% -9.24% -2.26% 1.04% 13.54% 12.30%
Operating Return on Assets (OROA)		 2.82% 8.39% -11.56% -3.15% 2.69% 10.77% -10.32% -4.50% 2.24% 11.42% -5.63%
Return on Assets (ROA)		 1.72% 6.14% -8.73% -3.04% -5.03% 8.04% -7.73% -5.70% 1.42% 10.63% -5.34%
Return on Common Equity (ROCE)		 5.77% 12.34% -20.28% -6.43% -15.40% 19.08% -18.44% -10.01% 4.46% 26.15% -10.81%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% -4.06% -0.11% -5.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 8.42 21 -22 -7.19 -22 34 -20 -10 6.16 48 -11
NOPAT Margin		 1.45% 2.88% -4.91% -1.37% -3.62% 4.59% -4.16% -1.85% 1.00% 6.01% -2.21%
Net Nonoperating Expense Percent (NNEP)		 2.29% 329.51% 2.94% 4.44% -3.08% 0.98% 2.19% 27.00% 1.25% -0.65% 6.89%
Return On Investment Capital (ROIC_SIMPLE)		 1.27% 3.51% -3.70% -1.18% -3.50% 6.25% -3.06% -1.75% 1.02% 8.42% -1.80%
Cost of Revenue to Revenue		 51.94% 53.71% 52.74% 53.23% 52.16% 53.13% 53.33% 54.22% 53.16% 54.11% 53.00%
SG&A Expenses to Revenue		 46.17% 41.08% 54.16% 48.58% 46.10% 40.46% 52.54% 48.40% 44.74% 39.06% 52.24%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 46.19% 41.24% 54.29% 48.73% 46.12% 40.69% 52.60% 48.43% 45.45% 39.47% 50.16%
Earnings before Interest and Taxes (EBIT)		 11 37 -32 -10 10 46 -28 -15 8.43 51 -16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 23 51 -19 2.81 23 59 -15 -1.11 22 64 -2.37
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.56 0.58 0.51 0.60 0.54 0.86 0.43 0.50 0.61 0.55 0.69
Price to Tangible Book Value (P/TBV)		 0.60 0.62 0.55 0.65 0.58 0.91 0.47 0.54 0.66 0.59 0.74
Price to Revenue (P/Rev)		 0.13 0.14 0.12 0.14 0.12 0.20 0.10 0.11 0.13 0.13 0.15
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8,030.14 23.53 19.22
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 4.25% 5.20%
Enterprise Value to Invested Capital (EV/IC)		 0.63 0.58 0.55 0.63 0.59 0.85 0.52 0.53 0.65 0.45 0.70
Enterprise Value to Revenue (EV/Rev)		 0.18 0.14 0.14 0.15 0.15 0.19 0.14 0.12 0.16 0.09 0.16
Enterprise Value to EBITDA (EV/EBITDA)		 9.01 9.35 11.38 6.09 5.97 6.57 4.65 4.32 5.81 3.01 4.81
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 67.05 73.99 32.00 18.64 21.57 32.61 12.65 13.52
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 87.60 96.82 0.00 0.00 0.00 0.00 11.56 17.70
Enterprise Value to Operating Cash Flow (EV/OCF)		 7.30 3.50 2.65 3.10 3.89 4.94 15.81 3.61 4.21 1.45 2.76
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 13.99 4.98 5.31 5.46 15.18 0.00 0.00 62.65 3.19 5.42
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.24 0.06 0.11 0.15 0.19 0.00 0.23 0.14 0.17 0.01 0.08
Long-Term Debt to Equity		 0.24 0.06 0.11 0.15 0.19 0.00 0.22 0.11 0.14 0.01 0.08
Financial Leverage		 0.15 0.00 0.11 0.12 0.16 -0.03 0.13 0.06 0.13 -0.12 0.11
Leverage Ratio		 2.76 2.37 2.48 2.70 2.78 2.38 2.53 2.70 2.82 2.45 2.59
Compound Leverage Factor		 2.19 2.27 2.55 3.05 2.45 2.34 2.65 2.97 2.53 2.43 2.64
Debt to Total Capital		 19.27% 5.72% 9.78% 12.75% 16.23% 0.00% 18.82% 12.29% 14.84% 0.59% 7.59%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.13% 2.30% 3.27% 0.00% 0.00%
Long-Term Debt to Total Capital		 19.27% 5.72% 9.78% 12.75% 16.23% 0.00% 17.68% 9.99% 11.57% 0.59% 7.59%
Preferred Equity to Total Capital		 0.12% 0.13% 0.13% 0.13% 0.13% 0.15% 0.13% 0.14% 0.14% 0.15% 0.14%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 80.61% 94.14% 90.09% 87.12% 83.64% 99.85% 81.05% 87.57% 85.03% 99.26% 92.27%
Debt to EBITDA		 2.85 0.98 2.10 1.34 1.72 0.00 1.73 1.07 1.38 0.05 0.55
Net Debt to EBITDA		 2.37 -0.01 1.42 0.55 1.14 0.00 1.42 0.45 0.96 -1.46 0.22
Long-Term Debt to EBITDA		 2.85 0.98 2.10 1.34 1.72 0.00 1.62 0.87 1.08 0.05 0.55
Debt to NOPAT		 -196.45 -3.68 -3.76 19.30 27.93 0.00 -5.25 -1.74 -75.32 0.19 2.02
Net Debt to NOPAT		 -163.20 0.05 -2.54 7.93 18.56 0.00 -4.31 -0.74 -52.57 -5.59 0.81
Long-Term Debt to NOPAT		 -196.45 -3.68 -3.76 19.30 27.93 0.00 -4.93 -1.42 -58.72 0.19 2.02
Altman Z-Score		 2.21 2.58 2.37 2.30 2.25 2.69 2.24 2.20 2.25 2.57 2.49
Noncontrolling Interest Sharing Ratio		 0.15% 0.14% 0.14% 0.15% 0.16% 0.15% 0.15% 0.16% 0.16% 0.15% 0.16%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.61 1.59 1.65 1.53 1.56 1.60 1.91 1.56 1.58 1.64 1.83
Quick Ratio		 0.20 0.28 0.23 0.26 0.20 0.22 0.23 0.23 0.19 0.39 0.23
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -18 54 58 55 38 92 -53 18 13 96 40
Operating Cash Flow to CapEx		 11.05% 1,120.08% -529.15% 350.96% -175.87% 851.79% -534.64% 588.09% -69.36% 1,756.58% -666.66%
Free Cash Flow to Firm to Interest Expense		 -8.34 35.39 65.00 41.15 31.65 114.69 -39.26 12.45 15.12 230.76 151.29
Operating Cash Flow to Interest Expense		 0.72 77.04 -37.91 20.61 -19.03 145.88 -75.46 59.18 -14.60 416.72 -387.82
Operating Cash Flow Less CapEx to Interest Expense		 -5.82 70.16 -45.08 14.73 -29.85 128.75 -89.57 49.12 -35.64 393.00 -445.99
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.53 1.67 1.64 1.60 1.58 1.74 1.73 1.68 1.64 1.79 1.76
Accounts Receivable Turnover		 43.76 49.23 44.13 42.67 42.41 45.37 45.49 42.25 44.03 54.94 48.73
Inventory Turnover		 2.25 2.93 2.81 2.59 2.36 3.05 2.94 2.64 2.35 3.05 2.83
Fixed Asset Turnover		 9.91 9.81 9.73 9.73 9.76 9.93 9.95 10.10 10.11 10.46 10.28
Accounts Payable Turnover		 5.94 9.44 9.60 6.89 6.12 8.69 10.73 6.60 5.95 8.06 10.47
Days Sales Outstanding (DSO)		 8.34 7.41 8.27 8.55 8.61 8.04 8.02 8.64 8.29 6.64 7.49
Days Inventory Outstanding (DIO)		 161.95 124.61 129.95 140.97 154.44 119.49 124.17 138.19 155.04 119.75 128.79
Days Payable Outstanding (DPO)		 61.48 38.65 38.03 53.01 59.65 42.00 34.01 55.27 61.32 45.28 34.87
Cash Conversion Cycle (CCC)		 108.81 93.37 100.19 96.52 103.40 85.53 98.19 91.56 102.01 81.12 101.41
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 643 571 589 565 583 513 622 536 576 465 571
Invested Capital Turnover		 3.67 3.96 3.66 3.86 3.78 4.29 3.87 4.29 4.11 4.98 4.11
Increase / (Decrease) in Invested Capital		 27 -33 -80 -63 -60 -58 33 -28 -7.20 -48 -51
Enterprise Value (EV)		 405 331 321 353 347 434 326 286 376 211 397
Market Capitalization		 298 331 280 321 280 467 226 255 313 312 378
Book Value per Share		 $46.60 $49.65 $47.72 $45.74 $45.99 $48.71 $47.24 $46.90 $47.51 $52.46 $50.80
Tangible Book Value per Share		 $43.49 $46.44 $44.55 $42.61 $42.74 $45.59 $43.90 $43.49 $44.16 $49.00 $47.39
Total Capital		 665 606 608 610 617 547 643 577 603 570 598
Total Debt		 128 35 59 78 100 0.00 121 71 90 3.38 45
Total Long-Term Debt		 128 35 59 78 100 0.00 114 58 70 3.38 45
Net Debt		 106 -0.47 40 32 67 -34 99 30 62 -102 18
Capital Expenditures (CapEx)		 14 11 6.38 7.90 13 14 19 15 19 9.87 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 220 153 181 165 204 195 288 204 246 137 244
Debt-free Net Working Capital (DFNWC)		 242 188 200 211 238 229 310 245 273 242 271
Net Working Capital (NWC)		 242 188 200 211 238 229 302 232 253 242 271
Net Nonoperating Expense (NNE)		 1.88 -5.94 1.86 2.80 -2.66 -0.17 1.53 8.36 0.81 0.44 4.05
Net Nonoperating Obligations (NNO)		 106 -0.47 40 32 67 -34 99 30 62 -102 18
Total Depreciation and Amortization (D&A)		 12 14 13 13 13 13 13 13 13 13 13
Debt-free, Cash-free Net Working Capital to Revenue		 9.51% 6.57% 7.86% 7.18% 8.80% 8.39% 12.30% 8.63% 10.32% 5.61% 9.95%
Debt-free Net Working Capital to Revenue		 10.45% 8.08% 8.69% 9.17% 10.25% 9.85% 13.23% 10.36% 11.46% 9.94% 11.06%
Net Working Capital to Revenue		 10.45% 8.08% 8.69% 9.17% 10.25% 9.85% 12.91% 9.80% 10.63% 9.94% 11.06%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.60 $2.29 ($2.23) ($0.91) ($1.76) $3.16 ($2.02) ($1.79) $0.52 $4.57 ($1.42)
Adjusted Weighted Average Basic Shares Outstanding		 10.90M 11.24M 10.93M 10.94M 10.74M 10.84M 10.50M 10.29M 10.33M 10.37M 10.43M
Adjusted Diluted Earnings per Share		 $0.60 $2.29 ($2.23) ($0.91) ($1.76) $3.16 ($2.02) ($1.79) $0.50 $4.56 ($1.42)
Adjusted Weighted Average Diluted Shares Outstanding		 10.97M 11.24M 10.93M 10.94M 10.74M 10.84M 10.50M 10.29M 10.67M 10.62M 10.43M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 11.49M 11.48M 11.63M 11.22M 11.21M 11.04M 10.78M 10.80M 10.79M 10.86M 11.11M
Normalized Net Operating Profit after Tax (NOPAT)		 8.49 22 -22 -6.65 7.24 36 -19 -10 9.28 51 -18
Normalized NOPAT Margin		 1.47% 2.97% -4.83% -1.27% 1.21% 4.76% -4.11% -1.84% 1.51% 6.40% -3.66%
Pre Tax Income Margin		 1.47% 4.82% -7.24% -2.23% 1.49% 6.06% -6.26% -2.94% 1.22% 6.35% -3.26%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 4.85 24.19 -36.22 -7.70 8.35 57.40 -21.15 -10.00 9.53 123.02 -58.92
NOPAT to Interest Expense		 3.81 13.83 -25.27 -5.35 -17.80 42.66 -14.71 -6.93 6.97 115.50 -40.62
EBIT Less CapEx to Interest Expense		 -1.69 17.32 -43.39 -13.57 -2.47 40.27 -35.27 -20.06 -11.51 99.29 -117.09
NOPAT Less CapEx to Interest Expense		 -2.73 6.96 -32.43 -11.22 -28.62 25.53 -28.83 -16.99 -14.07 91.78 -98.79
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -676.46% -203.70% -110.65% -1,876.76% -45.48% -65.44% -162.28% -60.47% 36,589.74% 104.63% 14.02%

Financials Breakdown Chart

Key Financial Trends

Genesco (NYSE: GCO) showed a sharp recovery in profitability in fiscal Q4 2026, but its latest Q1 2027 results were weak again, with a return to a net loss and negative operating cash flow. Over the last four years, the company has moved through significant swings in revenue, margins, working capital, and leverage, suggesting a business that remains highly sensitive to demand trends and cost control.

What stands out most is that Genesco’s profitability improved meaningfully from the loss period in early 2026 to strong earnings in Q4 2026, but that momentum did not carry into Q1 2027. The latest quarter featured lower revenue, a negative operating margin, and substantial cash consumption due largely to working capital pressure.

  • Q4 2026 was a strong quarter, with revenue of $799.9 million and net income of $47.6 million, reversing the losses seen in prior periods.
  • Gross profit improved in Q4 2026 to $367.1 million, showing better top-line leverage than in earlier quarters.
  • Operating cash flow was solid in Q4 2026 at $173.4 million, helped by a favorable change in operating assets and liabilities.
  • The company ended Q1 2027 with cash and equivalents of $27.1 million, up from $27.0 million in Q3 2026 and above the $19.2 million level in Q1 2025.
  • Common equity rose to $551.6 million in Q1 2027, up from $516.9 million in Q3 2025, indicating a stronger book equity base over time.
  • Revenue in Q1 2027 grew year over year to $487.0 million from $474.0 million in Q1 2026.
  • The company continues to manage a large inventory position, with inventories of $476.9 million in Q1 2027, which is lower than recent peaks but still a major balance-sheet item.
  • Debt levels remain meaningful but not excessive relative to equity, with total debt of about $45.3 million in Q1 2027 versus total equity of $552.4 million.
  • Q1 2027 returned to a net loss of $14.8 million, or $(1.42) per share, after profitable Q4 2026 results.
  • Operating income in Q1 2027 was a loss of $15.4 million, meaning SG&A exceeded gross profit and pressured margins.
  • Operating cash flow in Q1 2027 was deeply negative at $(102.8) million, driven by a large $105.1 million negative change in operating assets and liabilities.
  • Inventories surged from $392.7 million in Q1 2025 to $476.9 million in Q1 2027, which could point to heavier markdown risk or slower sell-through if demand softens.
  • Accounts payable and other current liabilities remain elevated, while total liabilities reached $831.6 million in Q1 2027, keeping leverage and working-capital management important.
  • Earnings have been volatile over the last several quarters: losses in Q1 and Q2 2026, a modest profit in Q3 2026, a strong Q4 2026, and then another loss in Q1 2027.

Bottom line: Genesco’s financial picture has improved from the weak first half of fiscal 2026, but the latest quarter shows that the turnaround is not yet stable. Investors should watch inventory trends, operating margins, and cash flow closely, since those will likely determine whether the Q4 2026 rebound can become a lasting trend.

07/05/26 03:09 PM ETAI Generated. May Contain Errors.

Genesco Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Genesco's fiscal year ends in January. Their fiscal year 2026 ended on January 31, 2026.

Genesco's net income appears to be on a downward trend, with a most recent value of $13.27 million in 2026, falling from $94.57 million in 2016. The previous period was -$18.89 million in 2025. Check out Genesco's forecast to explore projected trends and price targets.

Genesco's total operating income in 2026 was $17.31 million, based on the following breakdown:
  • Total Gross Profit: $1.13 billion
  • Total Operating Expenses: $1.11 billion

Over the last 10 years, Genesco's total revenue changed from $3.02 billion in 2016 to $2.44 billion in 2026, a change of -19.4%.

Genesco's total liabilities were at $825.93 million at the end of 2026, a 4.7% increase from 2025, and a 41.3% increase since 2016.

In the past 10 years, Genesco's cash and equivalents has ranged from $34.01 million in 2025 to $320.53 million in 2022, and is currently $105.41 million as of their latest financial filing in 2026.

Over the last 10 years, Genesco's book value per share changed from 43.19 in 2016 to 52.46 in 2026, a change of 21.5%.


Related Companies

Financial statements for NYSE:GCO last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel